Companies · Biotech

BLUUMBIOSummer 2021Active

San Francisco · CA, USA; Berkeley, CA, USA · Biotech · founded 2021 · http://www.bluumbio.com

Diligence memoA one-page analyst read on BLUUMBIO — recommendation, valuation, rhythm, risks.
Total raised · real
0
Rounds
Latest step-up
Top 34%
Sector rank · raised
Latest stage · inferred

BLUUMBIO: limited disclosed financing to assess.

Synthesized from the figures below est. — every claim rests on a number shown on this page.

Where it sits in Biotech

BLUUMBIO is one of 233 Biotech companies tracked from San Francisco, CA, USA; Berkeley, CA, USA, on record since 2021. By capital raised it ranks mid-pack (ahead of 67% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst

We make bacteria and plants that clean up pollution.

Our mission -To ensure current and future generations have access to clean soil, water & air. -To protect and restore earth's beautiful and diverse ecosystems. -To undo the harm of industrial activity on the planet and ensure future industrial activities are more sustainable. Our research -We develop new bio-based solutions that break down and remove toxic chemicals from the environment.  We also develop bioreactor based solutions which remove toxins from industrial production pipelines, ensuring contaminants are never released into the environment. -To do this, we've partnered with Nature. Specifically, we have harnessed the power of one of Nature's smallest but most powerful technologies: enzymes. Enzymes are everywhere. They break down the food in your stomach, remove dirt from your clothes, and make our beer. At BluumBio, we look for enzymes found in bacteria, algae, plants and other living organisms that naturally degrade toxic chemicals. We then make these enzymes work better in the lab and come up with develop new applications for these technologies.

BiotechSustainability
Find BLUUMBIO online

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

No round amounts on record to chart.

Financing ladder & sequence gaps

No staged rounds to sequence.

Modeled valuation trajectory
Base estimate est.
Conservative case
Upside case
Modeled post-money

Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Financing rhythm
Avg between rounds
Capital velocity
On record since
First round
0
Rounds on file
How it compares to the market

Benchmarked against 233 companies in Biotech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages)
This company
Sector median$7.8M
Modeled value — vs sector median (estimate, all stages)
This company
Sector median$56.1M

Raised more than 67% of sector peers (real $). Modeled value above 67% of peers (estimate).

Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
No rounds recorded.
Intelligence
Modeled next raise
Modeled next size est.
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Registry & provenance

BLUUMBIO is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
10x ScienceBiotechsame sector
1849 bioBiotechsame sector
1910Biotechsame sector
20nBiotechsame sector
54Gene, Inc.BiotechSeries B$48.3M$598.4Msame sector
Abacus Bioscience Inc.BiotechSeries A$4.4M$46.6Msame sector
Abalone BioBiotechsame sector
Acoustic Wave Cell Therapy, Inc.BiotechSeries A$20.5M$84.9Msame sector
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Birch Biosciences
We recycle plastic using engineered enzymes
Biotech78%
Cascade Biocatalysts, Inc.BiotechnologySeries A$16.8M76%
Solugen, Inc.
Decarbonizing the chemicals industry.
Climate / CleantechSeries D+$6.9B76%
Lygos, Inc.
Lygos engineers yeast to convert sugar into high-value industrial…
BiotechSeries B$432.7M75%
Alga Biosciences
We stop cows from burping methane.
Biotech75%
Living Carbon
maximizing biomass on low quality land
Biotech75%
Bariendo Inc.BiotechnologySeries A$40.9M74%
Clear Creek Bio, Inc.BiotechnologySeries A$37.1M74%
Frequently asked
What does BLUUMBIO do and where is it based?
BLUUMBIO operates in the Biotech sector, based in San Francisco, CA, USA; Berkeley, CA, USA. We make bacteria and plants that clean up pollution.
Explore related

See where BLUUMBIO sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at BLUUMBIO, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.